National Resilience

La Jolla, CA · Founded 2020 · Biotech · Private

Biopharmaceutical manufacturing platform and facilities for drug production

Claim this profile

Follows are private to you and power your alerts

Updated · resilience.com

Sector
Biotech
Headquarters
La Jolla, CA
Founded
2020
Latest Form D
$755M, Jan 2021
Total capital
$755M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$755M
1 Form D · last Jan 2021
70 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
40 pending

Capital timeline

2021FEDERAL ↑EQUITY ↓Cumulative $755M1st Form D$755M
2021FEDERAL ↑EQUITY ↓Cumulative $755M1st Form D$755M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$755M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Christopher E. DarbyDirectorNamed in SEC Form D filings
  • Denice M. TorresDirectorNamed in SEC Form D filings
  • Drew Robert OettingDirectorNamed in SEC Form D filings
  • Frances H. Arnold, Ph.D.DirectorNamed in SEC Form D filings
  • George H. BarrettDirectorNamed in SEC Form D filings
  • Joseph Robert KerreyDirectorNamed in SEC Form D filings
Show all 15 people
  • Kaye E. FosterDirectorNamed in SEC Form D filings
  • Mitchell E. Daniels, Jr.DirectorNamed in SEC Form D filings
  • Patrick Y. Yang. Ph.D.Director, Executive OfficerNamed in SEC Form D filings
  • Rahul Singhvi, Sc.D.Executive Officer, DirectorNamed in SEC Form D filings
  • Rich Y. Stoner, Ph.D.Executive OfficerNamed in SEC Form D filings
  • Robert NelsenDirectorNamed in SEC Form D filings
  • Sandesh Y. MahatmeExecutive OfficerNamed in SEC Form D filings
  • Scott E. Gottlieb, M.D.DirectorNamed in SEC Form D filings
  • Susan E. Desmond-Hellmann, M.D., MPHDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 40
  • PendingMethods, Kits, And Systems For Identification Of Vector Copy Number And Integration SitesUSPTOApplication 19455527
  • PendingBioreactor Systems and Methods of Operating SameUSPTOApplication 19124766
  • PendingMethods and Compositions for Preparing Recombinant Adeno Associated Viruses and Uses ThereofUSPTOApplication 19126974
Show all 40 patent records
  • Methods, Kits, And Systems For Identification Of Vector Copy Number And Integration SitesJul 23, 2026 · Application 19455527Pending
  • Bioreactor Systems and Methods of Operating SameJun 25, 2026 · Application 19124766Pending
  • Methods and Compositions for Preparing Recombinant Adeno Associated Viruses and Uses ThereofJun 25, 2026 · Application 19126974Pending
  • Systems, Methods, and Compositions for Selecting or Isolating CellsNov 27, 2025 · Application 19123686Pending
  • Systems, Methods, and Compositions for Generation of Therapeutic CellsNov 27, 2025 · Application 19128472Pending
  • Systems And Methods For Cell-free Polypeptide SynthesisAug 1, 2024 · Application 18473087Pending
  • Peptides, Nanovesicles, And Uses Thereof For Drug DeliveryJul 11, 2024 · Application 18555446Pending
  • Compositions of DNA Molecules, Methods of Making Therefor, and Methods of Use ThereofOct 12, 2023 · Application 18056931Pending
  • Compositions Of Dna Molecules, Methods Of Making Therefor, And Methods Of Use ThereofAug 31, 2023 · Application 18018151Pending
  • Cell-free Expression Vectors And Methods For Improved Protein ProductionApplication PCTUS2024015581Pending
  • Bacterial Strains for Protein GlycosylationApplication 63551265Pending
  • Physical Integration Device For On-line Purification AnalyticsApplication PCTUS2023085178Pending
  • Detecting Contaminants During Therapy Development And ManufactureApplication 63606823Pending
  • Systems, Methods, And Compositions For Generation Of Therapeutic CellsApplication PCTUS2023079368Pending
  • Methods And Compositions For Preparing Recombinant Adeno Associated Viruses And Uses ThereofApplication PCTUS2023078742Pending
  • Bioreactor Systems And Methods Of Operating SameApplication PCTUS2023077732Pending
  • Systems, Methods, And Compositions For Selecting Or Isolating CellsApplication PCTUS2023077579Pending
  • Biosecure Digital Twin For Cyber-physical Anomaly Detection And Biological Process ModelingApplication PCTUS2023076288Pending
  • Biosecure Digital Twin For Cyber-physical Anomaly Detection And Biological Process ModelingApplication 63580320Pending
  • Rotary Carousels And Rotary Valves For Analysis SystemsApplication 63516973Pending
  • Methods For Identification Of Vector Copy Number And Integration SitesApplication 63748170Pending
  • Optimized Bioprocessing For Scalable Cell-free Protein SynthesisApplication PCTUS2023017906Pending
  • Connectors For Preventing, Or Minmizing, Contamination In Process EnvironmentsApplication 63487765Pending
  • Biosecure Digital Twin For Cyber-physical Anomaly Detection And Biological Process ModelingApplication 63486925Pending
  • Systems, Methods, And Compositions For Selecting Or Isolating CellsApplication 63485853Pending
  • Indirect Sonication For Cell Extract Preparations For Cell-free Protein SynthesisApplication 63446781Pending
  • Cell-free Expression Vectors And Methods For Improved Protein ProductionApplication 63445245Pending
  • Physical Integration Device For On-line Purification AnalyticsApplication 63476709Pending
  • Systems, Methods, And Compositions For Generation Of Therapeutic CellsApplication 63383233Pending
  • Methods And Compositions For Preparing Recombinant Adeno Associated Viruses And Uses ThereofApplication 63382334Pending
  • Bioreactor Systems And Methods Of Operating SameApplication 63381096Pending
  • Systems, Methods, And Compositions For Selecting Or Isolating CellsApplication 63380687Pending
  • Biosecure Digital Twin For Cyber-physical Anomaly Detection And Biological Process ModelingApplication 63378848Pending
  • Systems And Methods For Cell-free Polypeptide SynthesisApplication PCTUS2022021651Pending
  • Indirect Sonication For Cell Extract Preparations For Cell-free Protein SynthesisApplication 19156776Pending
  • Simplified Preparation Of Cellular Extracts For Cell-free Protein SynthesisApplication 63165335Pending
  • Cell-free Expression Vectors And Methods For Improved Protein ProductionApplication 19155910Pending
  • Sterile Centrifuge Drive SystemsApplication PCTUS2025017594Pending
  • Bacterial Strains For Protein GlycosylationApplication PCTUS2025015053Pending
  • Detecting Contaminants During Therapy Development And ManufactureApplication PCTUS2024059027Pending
  • Natglycan, LLCSimilar federal contract value in Biotech · null in contracts
  • Tourmaline BioSimilar federal contract value in Biotech · null in contracts
  • MyOmeSimilar federal contract value in Biotech · null in contracts
  • Spirrow Therapeutics LLCSimilar federal contract value in Biotech · null in contracts
  • Annexon BiosciencesSimilar federal contract value in Biotech · null in contracts
  • Mosanna TherapeuticsSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .